Press Release: The Trump Administration today pulled its proposed rule to eliminate safe harbor protections for rebates paid by pharmaceutical manufacturers to PBMs and health plans in Medicare and Medicaid programs.
Press Release: Focusing on what’s best for the patient, leveraging technology to perform real-time benefit checks, and developing trust and transparency among stakeholders are some of the suggestions to emerge from AMCP’s recent Partnership Forum on “Optimizing Prior Authorization for Appropriate Medication Selection.”
Partnership Forum: Participants examined how to improve decision making for prior authorization and step therapy based on current market dynamics and considerations to ensure patients receive the most appropriate medications.
From News & Views: It is with great sadness that we report the recent passing of AMCP Past President Cathy Carroll. Cathy was a beloved, long-time member and leader of AMCP.
From News & Views: Section 3002 of the 21st Century Cures Act, which was signed into law in December 2016, requires the FDA to develop one or more sets of new guidances regarding the collection of patient experience data.
The Academy of Managed Care Pharmacy (AMCP) is pleased to share our thoughts on the “Lower Health Care Costs Act” (“the Act”) as released on May 23, 2019 by the Committee on Health, Education, Labor and Pensions (“HELP Committee”).
The Academy of Managed Care Pharmacy (AMCP) thanks the Office of the National Coordinator for Health Information Technology (ONC) for the opportunity to provide comments in response to its proposed rule “21st Century Cures Act: Interoperability, Information Blocking, and the Health IT Certification Program” published in the Federal Register on March 4, 2019. AMCP appreciates ONC’s effort to remove barriers to interoperability and health information exchange.